Evidence map›Paper›PMID 32678268›Full record

ArticleScientific reports2020

Preliminary results in the analysis of the immune response after aneurysmal subarachnoid hemorrhage.

Jorge A Roa, Deepon Sarkar, Mario Zanaty, Daizo Ishii, Yongjun Lu, Nitin J Karandikar, David M Hasan, Sterling B Ortega, Edgar A Samaniego

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 3 pooled it
1.8field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 3 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Observational
  6. Observational
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Role of microglia after subarachnoid hemorrhage.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2024
    Review
  14. Article
  15. Article
  16. Review
  17. Natural killer cells in the central nervous system.Cell communication and signaling : CCS · 2023
    Review
  18. Immunological Profile of Vasospasm after Subarachnoid Hemorrhage.International journal of molecular sciences · 2023
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Jorge A RoaDepartment of Neurology, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.
Deepon SarkarDepartment of Neurology, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.
Mario ZanatyDepartment of Neurosurgery, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.
Daizo IshiiDepartment of Neurosurgery, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.
Yongjun LuDepartment of Neurosurgery, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.
Nitin J KarandikarDepartment of Pathology, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.
David M HasanDepartment of Neurosurgery, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.
Sterling B OrtegaDepartment of Pathology, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.
Edgar A SamaniegoDepartment of Neurology, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA. edgarsama@gmail.com.
University of Iowa Hospitals and Clinics · US

Funding

PROGRAM IN HEMOSTASIS AND THROMBOSIS FOR ACADEMICT32HL007344 · NHLBI · UNIVERSITY OF IOWA · PI Anil Kumar Chauhan, Steven R Lentz · 1985 to 2026
$6.5M
NHLBI NIH HHS T32 HL007344
6 · The paper itself

Abstract

Cerebral vasospasm (VSP) is a common phenomenon after aneurysmal subarachnoid hemorrhage (aSAH) and contributes to neurocognitive decline. The natural history of the pro-inflammatory immune response after aSAH has not been prospectively studied in human cerebrospinal fluid (CSF). In this pilot study, we aimed to identify specific immune mediators of VSP after aSAH. Peripheral blood (PB) and CSF samples from patients with aSAH were prospectively collected at different time-points after hemorrhage: days 0-1 (acute); days 2-4 (pre-VSP); days 5-9 (VSP) and days 10 + (post-VSP peak). Presence and severity of VSP was assessed with computed tomography angiography/perfusion imaging and clinical examination. Cytokine and immune mediators' levels were quantified using ELISA. Innate and adaptive immune cells were characterized by flow cytometry, and cell counts at different time-points were compared with ANOVA. Confocal immunostaining was used to determine the presence of specific immune cell populations detected in flow cytometry. Thirteen patients/aneurysms were included. Five (38.5%) patients developed VSP after a mean of 6.8 days from hemorrhage. Flow cytometry demonstrated decreased numbers of CD45+ cells during the acute phase in PB of aSAH patients compared with healthy controls. In CSF of VSP patients, NK cells (CD3-CD161 +) were increased during the acute phase and progressively declined, whereas CD8+CD161+ lymphocytes significantly increased at days 5-9. Microglia cells (CD45dimCD11b +) increased over time after SAH. This increase was particularly significant in patients with VSP. Levels of VEGF and MMP-9 were consistently higher in VSP patients, with the highest difference occurring at the acute phase. Confocal immunostaining demonstrated the presence of CD8+CD161+ lymphocytes in the arterial wall of two unruptured intracranial aneurysms. In this preliminary study, human CSF showed active presence of innate and adaptive immune cells after aSAH. CD8+CD161+ lymphocytes may have an important role in the inflammatory response after aneurysmal rupture and were identified in the aneurysmal wall of unruptured brain aneurysms. Microglia activation occurs 6 + days after aSAH.

Indexed as

ImmunityAdaptive ImmunityAdultAgedAged, 80 and overAneurysm, RupturedBiomarkersCytokinesFemaleHumansImmunity, InnateImmunohistochemistryInflammation MediatorsMaleMiddle AgedSubarachnoid HemorrhageBiomarkersCytokinesInflammation Mediators

Identifiers

PMID32678268
PMCPMC7367262
OpenAlexW3042871645

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.